Polygenic in vivo validation of cancer mutations using transposons
Su Kit Chew(Wellcome Sanger Institute), PA Futreal(The University of Texas MD Anderson Cancer Center), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Adam Collinson(Babraham Institute), Juexuan Wang(Wellcome Sanger Institute), David Jones(European Bioinformatics Institute), John Gamble(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Sarah O¿Meara(Wellcome Sanger Institute), Stuart McLaren(Wellcome Sanger Institute), Jonathan Hinton(Wellcome Sanger Institute), Lia S. Campos(Universidade Federal de Minas Gerais), Lu Dong(Anhui Medical University), Lynda Chin(American Productivity and Quality Center), Jon W. Teague(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Kenneth L. Scott(Dana-Farber Cancer Institute), Abdel Saci(Harvard University), Keiran Raine(Wellcome Sanger Institute)
Cited by 0
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k